[CAS NO. 1258861-20-9] Taladegib (LY2940680)
Please click "REQUEST A QUOTE" button if you need other sizes or
custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis,
please:
PRODUCTS SPECIFICATIONS [1258861-20-9]
Catalog
SLK-S2157
Brand
Selleck
CAS
1258861-20-9
DESCRIPTION [1258861-20-9]
Overview
| MDL | MFCD21609264 |
|---|---|
| Molecular Weight | 512.5 |
| Molecular Formula | C26H24F4N6O |
| SMILES | O=C(N(C)C1CCN(C2=NN=C(C3=CC=NN3C)C4=C2C=CC=C4)CC1)C5=CC=C(F)C=C5C(F)(F)F |
For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
1 years,-80°C,in solvent
Shipping
Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
| 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.9512 mL | 9.7561 mL | 19.5122 mL |
| 5 mM | 0.3902 mL | 1.9512 mL | 3.9024 mL |
| 10 mM | 0.1951 mL | 0.9756 mL | 1.9512 mL |
| 50 mM | 0.0390 mL | 0.1951 mL | 0.3902 mL |
Description
Taladegib (LY2940680) binds to the (Smo) receptor and potently inhibits (Hh) signaling. Phase 1/2.
Targets
| Smoothened [1] |
In vitro
LY2940680 inhibits cancer growth in cell lines containing a mutation in the gene encoding Smoothened that researchers had previously observed in patient with cancer who developed resistance to vismodegib.
In vivo
LY2940680 has excellent pharmacokinetic properties in rodent and non-rodent species. LY2940680 administrated orally treats Ptch p53 transgenic mice which spontaneously develop medulloblastoma, produces remarkable efficacy and significantly improves their survival. LY2940680 reveals rapid kinetics of anti-tumor activity through magnetic resonance imaging of these mice, and LY2940680 induces Caspase-3 activity and reduces proliferation by immunohistochemistry analysis of medulloblastoma tumors. LY2940680 inhibits Hh regulated gene expression in the subcutaneous xenograft tumor stroma and produces significant anti-tumor activity.
References
Powered by Arctom Copyright © 2025 Arctom.
All rights reserved.